Frontiers in neuroscience

Redefining Central Nervous System Therapies

Neurolynx is a pre-clinical and clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervous system, or CNS, disorders, who have unmet medical needs. We believe that each of our programs has the potential to change the current treatment paradigm and establish a new standard of care across a number of neurologic disorders.

CNS disorders are a diverse group of conditions that include neurological, psychiatric, and substance abuse disorders. Our discovery platform currently focuses on single molecules that function through multiple mechanisms designed to target the complexity of the CNS disease state. We believe that this approach may potentially offer new treatment options for patients, including those who are refractory to currently available treatments. Our current focus is in the therapeutic areas of rare hypersomnia disorders (conditions characterized by excessive daytime sleepiness, or EDS, such as narcolepsy) and complex neurodevelopmental disorders.